GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Mini-glucagon

Company
Insel Gruppe AG, University Hospital Bern
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details
  • Status unknown NCT NCT01402037

    Beta Cell Function in (Pre)Type 1 Diabetes

    Not yet reported Universitair Ziekenhuis Brussel 100 participants Est. completion 2016-07 3 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01680653

    Testing State of the Art Remote Glucose Monitoring at Diabetes Camp

    Not yet reported Stanford University 57 participants Est. completion 2012-09 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02081014

    Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes

    Not yet reported Xeris Pharmaceuticals 13 participants Est. completion 2014-11 1 site
    Other conditions: Hypoglycemia
    View official trial listing →
  • Completed NCT NCT02189694

    Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes Camp

    Not yet reported Institut de Recherches Cliniques de Montreal 33 participants Est. completion 2014-08 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02282254

    Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Type 1 Diabètes Adults With Hypoglycemia Unawareness and Documented Nocturnal Hypoglycemia

    Not yet reported Institut de Recherches Cliniques de Montreal 35 participants Est. completion 2016-07 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02411578

    Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia

    Not yet reported Jaeb Center for Health Research 26 participants Est. completion 2016-05 5 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02638805

    Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide

    Not yet reported Intarcia Therapeutics 136 participants Est. completion 2017-10 36 sites Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02660242

    The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes

    Not yet reported Jaeb Center for Health Research 16 participants Est. completion 2017-02-15 2 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Withdrawn NCT NCT02846857

    Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT03970772

    Mini-Dose Glucagon to Treat Fasting-induced Hypoglycemia During Ramadan

    Not yet reported Qassim University 20 participants Est. completion 2019-08-15 1 site
    Other conditions: Fasting Hypoglycemia, Diabetes Mellitus, Type 1
    View official trial listing →
  • Withdrawn NCT NCT04192019

    Micro Glucagon During Exercise in Type 1 Diabetes

    Not yet reported Insel Gruppe AG, University Hospital Bern Est. completion 2024-06 Stand-alone
    Other conditions: Type 1 Diabetes, Hypoglycemia
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.